The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
LDL Cholesterol and the Development of Stroke Subtypes and Coronary Heart Disease in a General Japanese Population: The Hisayama Study
Abstract
Background and Purpose— Although the relation between serum LDL cholesterol level and coronary heart disease (CHD) is well established, its relation with stroke subtypes is less clear. Methods— A total of 2351 inhabitants age ≥40 years in a Japanese community were followed up for 19 years. Results— During follow-up, 271 subjects developed stroke and 144 developed CHD. Whereas the age- and sex-adjusted incidences of CHD significantly increased with increasing LDL cholesterol levels ( P for trend <0.001), the associations between LDL cholesterol level and the incidences of ischemic or hemorrhagic stroke were not significant. The age- and sex-adjusted incidences of atherothrombotic infarctions (ATIs) and lacunar infarctions (LIs) significantly increased with increasing LDL cholesterol level ( P for trend=0.03 for ATIs and=0.02 for LIs), but no such association was observed for cardioembolic infarction. After multivariate adjustment, the positive associations of LDL cholesterol level with the risks of ATI and CHD remained significant ( P for trend=0.02 for ATIs and=0.03 for CHD), whereas the association with LIs was not significant. The risk of ATI significantly increased in the fourth quartile of LDL cholesterol compared with the first quartile (multivariate-adjusted hazard ratio=2.84; 95% CI, 1.17 to 6.93). The multivariate-adjusted risks for developing nonembolic infarction (ATIs and LIs) and CHD were significantly elevated in the groups with elevated LDL cholesterol values with and without the metabolic syndrome. Conclusions— Our findings suggest that an elevated LDL cholesterol level is a significant risk factor for developing ATI as well as CHD, and these associations are independent of the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the increase in hazard ratio for the CAD incidence and mortality following an elevation in LDL-C has been validated in cohort studies involving the Japanese36–40).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“An elevated LDL-C level also increased the risk for cerebral thrombosis (except lacunar infarction) among the subtypes of ischemic stroke36).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“among stroke cases, the percentage of atherothrombotic cerebrovascular disease in which LDL-C was a risk factor is approximately 20%36)”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“LDL-C is also a risk factor for atherothrombotic cerebral infarction36), and the effectiveness of statins to decrease the incidence of atherothrombotic cerebral infarction was confirmed in a Japanese population by the J-STARS study619).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“The results of the Hisayama study, which investigated cerebral infarction risk by type, demonstrated that the LDL-C level is a risk factor for atherothrombotic cerebral infarction.”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“However, the results of epidemiological studies conducted in Japan have indicated that there is no significant relationship between the serum cholesterol levels (TC, LDL-C, and non-HDL-C) and the incidence rate of noncardiogenic cerebral infarction36, 38, 40, 57, 64, 78, 337).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
In the citing paper
“However, the LDL-C level is not related to the incidence of other types of cerebral infarction36).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [36]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,350
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Incidence of and risk factors for atrial fibrillation in older adults
Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., White, R., Furberg, C. D., & Rautaharju, P. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2455 · Cited by 1,462
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Self-citationAmarenco, P., & Labreuche, J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70058-4 · Cited by 660
Cholesterol Levels and Risk of Hemorrhagic Stroke
Wang, X., Dong, Y., Qi, X., Huang, C.-G., & Hou, L. (2013) · Stroke · doi:10.1161/strokeaha.113.001326 · Cited by 343
Duran, E. K., Aday, A. W., Cook, N. R., Buring, J. E., Ridker, P. M., & Pradhan, A. D. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.059 · Cited by 347
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 345
Self-citationSecular Trends in Cardiovascular Disease and Its Risk Factors in Japanese
Hata, J., Ninomiya, T., Hirakawa, Y., Nagata, M., Mukai, N., Gotoh, S., Fukuhara, M., Ikeda, F., Shikata, K., Yoshida, D., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002424 · Cited by 287
Self-citationCardiovascular Disease Epidemiology in Asia
Ohira, T., & Iso, H. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0702 · Cited by 253
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism
Ohno, Y., Sone, M., Inagaki, N., Yamasaki, T., Ogawa, O., Takeda, Y., Kurihara, I., Itoh, H., Umakoshi, H., Tsuiki, M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10263 · Cited by 200
Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage
Ma, C., Gurol, M. E., Huang, Z., Lichtenstein, A. H., Wang, X., Wang, Y., Neumann, S., Wu, S., & Gao, X. (2019) · Neurology · doi:10.1212/wnl.0000000000007853 · Cited by 199
Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes
Hindy, G., Engström, G., Larsson, S. C., Traylor, M., Markus, H. S., Melander, O., & Orho‐Melander, M. (2018) · Stroke · doi:10.1161/strokeaha.117.019653 · Cited by 192
The effects of probiotic and conventional yoghurt on lipid profile in women
Sadrzadeh-Yeganeh, H., Elmadfa, I., Djazayery, A., Jalali, M., Heshmat, R., & Chamary, M. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114509993801 · Cited by 179
Epidemiology and prevention of stroke: a worldwide perspective
Kuklina, E. V., Tong, X., George, M. G., & Bansil, P. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.99 · Cited by 184
Lipids and Cerebrovascular Disease: Research and Practice
Yaghi, S., & Elkind, M. S. V. (2015) · Stroke · doi:10.1161/strokeaha.115.011164 · Cited by 176
Ogino, H., Iida, O., Akutsu, K., Chiba, Y., Hayashi, H., Ishibashi‐Ueda, H., Kaji, S., Kato, M., Komori, K., Matsuda, H., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0794 · Cited by 182
Epidemiology of Stroke and Coronary Artery Disease in Asia
Hata, J., & Kiyohara, Y. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0786 · Cited by 172
Self-citationYamagishi, K., Nettleton, J. A., & Folsom, A. R. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.017 · Cited by 155
2017 Taiwan lipid guidelines for high risk patients
Li, Y., Ueng, K., Jeng, J., Charng, M., Lin, T., Chien, K., Wang, C., Chao, T., Liu, P., Su, C., et al. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.11.013 · Cited by 166
Effect of Probiotics on Blood Lipid Concentrations: A Meta-Analysis of Randomized Controlled Trials
Cho, Y. A., & Kim, J. (2015) · Medicine · doi:10.1097/md.0000000000001714 · Cited by 143
Lipid levels and the risk of hemorrhagic stroke among women
Rist, P. M., Buring, J. E., Ridker, P. M., Kase, C. S., Kurth, T., & Rexrode, K. M. (2019) · Neurology · doi:10.1212/wnl.0000000000007454 · Cited by 128
LDL and HDL subclasses in acute ischemic stroke: Prediction of risk and short-term mortality
Zeljković, A., Vekić, J., Spasojević‐Kalimanovska, V., Jelić‐Ivanović, Z., Bogavac‐Stanojević, N., Gulan, B., & Spasić, S. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.040 · Cited by 131
D’Isabella, N. T., Shkredova, D. A., Richardson, J. A., & Tang, A. (2017) · Clinical Rehabilitation · doi:10.1177/0269215517709051 · Cited by 118
Japanese Legacy Cohort Studies: The Hisayama Study
Ninomiya, T. (2018) · Journal of Epidemiology · doi:10.2188/jea.je20180150 · Cited by 115
Lipids and Lipid Mediators Associated with the Risk and Pathology of Ischemic Stroke
Kłoska, A., Malinowska, M., Gabig‐Cimińska, M., & Jakóbkiewicz‐Banecka, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103618 · Cited by 116
LOX Index, a Novel Predictive Biochemical Marker for Coronary Heart Disease and Stroke
Inoue, N., Okamura, T., Kokubo, Y., Fujita, Y., Sato, Y., Nakanishi, M., Yanagida, K., Kakino, A., Iwamoto, S., Watanabe, M., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.140707 · Cited by 114
Nagasawa, S., Okamura, T., Iso, H., Tamakoshi, A., Yamada, M., Watanabe, M., Murakami, Y., Miura, K., Ueshima, H., & for the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH‐JAPAN) Research Group (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.001974 · Cited by 101
Yamagishi, K., Iso, H., Yatsuya, H., Tanabe, N., Date, C., Kikuchi, S., Yamamoto, A., Inaba, Y., & Tamakoshi, A. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29146 · Cited by 101
Tanabe, N., Iso, H., Okada, K., Nakamura, Y., Harada, A., Ohashi, Y., Ando, T., Ueshima, H., & The Japan Arteriosclerosis Longitudinal Study Group (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0861 · Cited by 99
Imano, H., Noda, H., Kitamura, A., Sato, S., Kiyama, M., Sankai, T., Ohira, T., Nakamura, M., Yamagishi, K., Ikeda, A., et al. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.02.019 · Cited by 97
Location of cerebral atherosclerosis: Why is there a difference between East and West?
Kim, J. S., Kim, Y. J., Ahn, S. H., & Kim, B. J. (2016) · International Journal of Stroke · doi:10.1177/1747493016647736 · Cited by 99
Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms
Stanzione, R., Cotugno, M., Bianchi, F., Marchitti, S., Forte, M., Volpe, M., & Rubattu, S. D. (2020) · Genes · doi:10.3390/genes11010089 · Cited by 94
Higashioka, M., Sakata, S., Honda, T., Hata, J., Yoshida, D., Hirakawa, Y., Shibata, M., Gotō, K., Kitazono, T., Osawa, H., et al. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.51961 · Cited by 88
Self-citationYokokawa, H., Yasumura, S., Tanno, K., Ohsawa, M., Onoda, T., Itai, K., Sakata, K., Kawamura, K., Tanaka, F., Yoshida, Y., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5215 · Cited by 83
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 91
Self-citationMiller, A. A., Silva, T. M. D., Judkins, C. P., Diep, H., Drummond, G. R., & Sobey, C. G. (2010) · Stroke · doi:10.1161/strokeaha.109.575365 · Cited by 77
Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids
Torres, M., Parets, S., Fernández-Díaz, J., Beteta-Göbel, R., Rodríguez-Lorca, R., Román, R., Lladó, V., Rosselló, C. A., Fernández‐García, P., & Escribá, P. V. (2021) · Membranes · doi:10.3390/membranes11120919 · Cited by 80
Canouï‐Poitrine, F., Luc, G., Bard, J., Ferrières, J., Yarnell, J., Arveiler, D., Morange, P., Kee, F., Evans, A., Amouyel, P., et al. (2010) · Cerebrovascular Diseases · doi:10.1159/000319067 · Cited by 70
Ma, C., Na, M., Neumann, S., & Gao, X. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0815-5 · Cited by 68
How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol
Karagiannis, A. D., Mehta, A., Dhindsa, D. S., Virani, S. S., Orringer, C. E., Blumenthal, R. S., Stone, N. J., & Sperling, L. S. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1080 · Cited by 70
Arima, H., Yonemoto, K., Doi, Y., Ninomiya, T., Hata, J., Tanizaki, Y., Fukuhara, M., Matsumura, K., Iida, M., & Kiyohara, Y. (2009) · Hypertension Research · doi:10.1038/hr.2009.161 · Cited by 66
Self-citationYamagishi, K., Folsom, A. R., Steffen, L. M., & for the ARIC Study Investigators (2013) · Cerebrovascular Diseases · doi:10.1159/000351205 · Cited by 67
Honda, T., Chen, S., Hata, J., Yoshida, D., Hirakawa, Y., Furuta, Y., Shibata, M., Sakata, S., Kitazono, T., & Ninomiya, T. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.61960 · Cited by 62
Self-citationOura, K., Kato, T., Ohba, H., & Terayama, Y. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.04.023 · Cited by 61
Cholesterol Lowering and Prevention of Stroke
Hackam, D. G., & Hegele, R. A. (2019) · Stroke · doi:10.1161/strokeaha.118.023167 · Cited by 66
Lv, P., Jin, H., Liu, Y., Cui, W., Peng, Q., Liu, R., Sun, W., Fan, C., Teng, Y., Sun, W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149605 · Cited by 57
Yamashita, K., Kondo, T., Osugi, S., Shimokata, K., Maeda, K., Okumura, N., Matsudaira, K., Shintani, S., Muramatsu, T., Matsushita, K., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0337 · Cited by 57
Khanna, N. N., Jamthikar, A. D., Araki, T., Gupta, D., Piga, M., Saba, L., Carcassi, C., Nicolaides, A. N., Laird, J. R., Suri, H. S., et al. (2019) · Echocardiography · doi:10.1111/echo.14242 · Cited by 55
Satoh, M., Ohkubo, T., Asayama, K., Murakami, Y., Sakurai, M., Nakagawa, H., Iso, H., Okayama, A., Miura, K., Imai, Y., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04639 · Cited by 54
Yeh, P.-S., Yang, C.-M., Lin, S., Wang, W.-M., Chen, P.-S., Chao, T., Lin, H.-J., Lin, K., Chang, C., Cheng, T., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.015 · Cited by 51
Kuwashiro, T., Sugimori, H., Ago, T., Kamouchi, M., Kitazono, T., & for the FSR Investigators (2011) · Cerebrovascular Diseases · doi:10.1159/000334190 · Cited by 51
The clinical application of ultrasonography with superb microvascular imaging‐a review
Tang, K., Liu, M., Zhu, Y., Zhang, M., & Niu, C. (2022) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23210 · Cited by 49
Noda, H., Iso, H., Irie, F., Sairenchi, T., Ohtaka, E., & Ohta, H. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02183.x · Cited by 48
Imamura, T., Doi, Y., Ninomiya, T., Hata, J., Nagata, M., Ikeda, F., Mukai, N., Hirakawa, Y., Yoshida, D., Fukuhara, M., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.005 · Cited by 47
Self-citationJCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease
Fujiyoshi, A., Kohsaka, S., Hata, J., Hara, M., Kai, H., Masuda, D., Miyamatsu, N., Nishio, Y., Ogura, M., Sata, M., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0285 · Cited by 55
Self-citationSesame fractions and lipid profiles: a systematic review and meta-analysis of controlled trials
Khalesi, S., Sofija, E., Nikbakht, E., & Khosravi‐Boroujeni, H. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114515005012 · Cited by 46
Sugiyama, D., Okamura, T., Watanabe, M., Higashiyama, A., Okuda, N., Nakamura, Y., Hozawa, A., Kita, Y., Kadota, A., Murakami, Y., et al. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.25908 · Cited by 44
The associations of lipids and lipid ratios with stroke: A prospective cohort study
Liu, X., Ling, Y., & Xue, F. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13441 · Cited by 46
Wu, J., Chen, S., Liu, L., Gao, X., Zhou, Y., Wang, C., Zhang, Q., Wang, A., Hussain, M., Sun, B., et al. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000206 · Cited by 42
Tan, Y., Zhan, L., Chen, X.-H., Guo, J., Qin, C., & Xu, E. (2018) · Current Medical Science · doi:10.1007/s11596-018-1878-1 · Cited by 41
Kim, M. K., Han, K., Joung, H. N., Baek, K., Song, K., & Kwon, H. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0943-9 · Cited by 41
Frappier, M., Auclair, J., Bouasker, S., Gunaratnam, S., Diarra, C., & Millette, M. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09959-9 · Cited by 44
Okamura, T., Kokubo, Y., Watanabe, M., Higashiyama, A., Ono, Y., Nishimura, K., Okayama, A., & Miyamoto, Y. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.010 · Cited by 38
Alvarez-Perez, F. J., Castelo-Branco, M., & Álvarez‐Sabín, J. (2010) · International Journal of Neuroscience · doi:10.3109/00207454.2010.523134 · Cited by 38
Choi, K., Park, M., Kim, J., Chang, J., Nam, T., Choi, S., Lee, S., Kim, B. C., Kim, M., & Cho, K. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.04.018 · Cited by 37
Sleep, Autonomic Nervous Function and Atherosclerosis
Kadoya, M., & Koyama, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040794 · Cited by 38
Okamura, T., Kokubo, Y., Watanabe, M., Higashiyama, A., Ono, Y., Miyamoto, Y., Yoshimasa, Y., & Okayama, A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.012 · Cited by 35
The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature
Zhao, S., Wang, Z., & Xiao, Z.-J. (2019) · Neurology India · doi:10.4103/0028-3886.266274 · Cited by 35
Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
Doi, T., Langsted, A., & Nordestgaard, B. G. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22013 · Cited by 37
Kurabayashi, T., Mizunuma, H., Kubota, T., Kiyohara, Y., Nagai, K., & Hayashi, K. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.04.002 · Cited by 34
Self-citationStatins and stroke: prevention and beyond
Prinz, V., & Endres, M. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283424c53 · Cited by 33
Serum lipid profiles and post-stroke depression in acute ischemic stroke patients
Shen, H., Tu, X., Luan, X., Zeng, Y., He, J., & Tang, W. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s204791 · Cited by 33
Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment
Zhai, T., Wang, P., Hu, X., & Zheng, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3900835 · Cited by 34
Non-High-Density Lipoprotein Cholesterol on the Risks of Stroke: A Result from the Kailuan Study
Wu, J., Chen, S., Zhou, Y., Wang, C., Wang, A., Zhang, Q., Gao, X., Hu, H., Wu, S., & Zhao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074634 · Cited by 31
Shitara, S., Fujiyoshi, A., Hisamatsu, T., Torii, S., Suzuki, S., Ito, T., Arima, H., Shiino, A., Nozaki, K., Miura, K., et al. (2019) · Stroke · doi:10.1161/strokeaha.119.025964 · Cited by 29
Self-citationLipid levels and the risk of hemorrhagic stroke: A dose–response meta-analysis
Jin, X., Chen, H., Shi, H., Fu, K., Li, J., Li, T. X., & Teng, W. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.10.014 · Cited by 30
Kawase, A., Yamada, A., Gamou, Y., Tahara, C., Takeshita, F., Murata, K., Matsuda, H., Samukawa, K., & Iwaki, M. (2012) · Journal of Natural Medicines · doi:10.1007/s11418-012-0713-4 · Cited by 29
Molecular mechanisms underlying some major common risk factors of stroke
Alkahtani, R. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10218 · Cited by 33
Liu, J., Wang, W., Wang, M., Sun, J., Liu, J., Li, Y., Qi, Y., Wu, Z., & Zhao, D. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.018 · Cited by 28
Estimation of the presence of small dense lipoprotein cholesterol in acute ischemic stroke
Manabe, Y., Morihara, R., Matsuzono, K., Nakano, Y., Takahashi, Y., Narai, H., Omori, N., & Abe, K. (2015) · Neurology International · doi:10.4081/ni.2015.5973 · Cited by 27
Tews, H. C., Schmelter, F., Kandulski, A., Büchler, C., Schmid, S. A., Schlosser, S., Elger, T., Loibl, J., Sommersberger, S., Fererberger, T., et al. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad298 · Cited by 25
Todate, Y., Uwano, I., Yashiro, S., Chida, A., Hasegawa, Y., Oda, T., Nagasawa, K., Honma, H., Sasaki, M., & Ishigaki, Y. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48553 · Cited by 26
Banach, M., Shekoohi, N., Mikhailidis, D. P., Lip, G. Y. H., Hernández, A. V., & Mazidi, M. (2022) · Archives of Medical Science · doi:10.5114/aoms/145970 · Cited by 30
Xing, Y., An, Z., Yu, N., Zhao, W., Ning, X., & Wang, J. (2016) · European Neurology · doi:10.1159/000450604 · Cited by 25
Palacio-Portilla, E. J., Roquer, J., Amaro, S., Arenillas, J. F., Martín, Ó. A., Castellanos, M., Freijo, M. D. M., Fuentes, B., Pastor, Á. G., Gomis, M., et al. (2020) · Neurología · doi:10.1016/j.nrl.2020.07.027 · Cited by 22
Atherosclerotic Cardiovascular Disease Risk Prediction Models in China, Japan, and Korea
Nguyen, P. K. P., Zhao, D. H., Okamura, T., Kim, H. C., Wong, N. D., & Yang, E. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.01.006 · Cited by 23
Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence
Hosomi, N., Kitagawa, K., Nagai, Y., Nakagawa, Y., Aoki, S., Nezu, T., Kagimura, T., Maruyama, H., Origasa, H., Minematsu, K., et al. (2018) · Stroke · doi:10.1161/strokeaha.117.018870 · Cited by 23
A Study of Serum Apolipoprotein A1, Apolipoprotein B and Lipid Profile in Stroke
Shilpasree, A. S. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/5269.3123 · Cited by 23
Sone, Y., Kido, T., Ainuki, T., Sonoda, M., Ichi, I., Kodama, S., Sone, H., Kondo, K. N., Morita, Y., Egawa, S., et al. (2013) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.59.325 · Cited by 23
Saadatagah, S., Alhalabi, L., Farwati, M., Zordok, M., Bhat, A., Smith, C. Y., Wood‐Wentz, C. M., Bailey, K. R., & Kullo, I. J. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100393 · Cited by 21
Risk factor profile by etiological subtype of ischemic stroke in the young.
Jaffre, A., Ruidavets, J., Calvière, L., Viguier, A., Ferrières, J., & Larrue, V. (2014) · Clinical neurology and neurosurgery (Dutch-Flemish ed. Print) · doi:10.1016/j.clineuro.2014.02.017 · Cited by 24
Different Risk Factor Profiles between Silent Brain Infarction and Symptomatic Lacunar Infarction
Kim, M.-H., Moon, J., Park, S., An, S.-A., Kim, O.-J., Kim, N. K., & Oh, S. (2011) · European Neurology · doi:10.1159/000324335 · Cited by 21
Stroke and Etiopathogenesis: What Is Known?
Ciarambino, T., Crispino, P., Mastrolorenzo, E., Viceconti, A., & Giordano, M. (2022) · Genes · doi:10.3390/genes13060978 · Cited by 20
Ma, X., Chen, H., Cao, L., Zhao, S., Zhao, C., Yin, S., Fan, L., & Hu, H. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.017 · Cited by 20
Ohmoto‐Sekine, Y., Yanagibori, R., Amakawa, K., Ishihara, M., Tsuji, H., Ogawa, K., Ishimura, R., Ishiwata, S., Ohno, M., Yamaguchi, T., et al. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.06.010 · Cited by 21
Current status of statin therapy for stroke prevention
Sett, A. K., Robinson, T. G., & Mistri, A. K. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.106 · Cited by 19
Komiyama, T., Ohi, T., Miyoshi, Y., Murakami, T., Tsuboi, A., Tomata, Y., Tsuji, I., Watanabe, M., & Hattori, Y. (2018) · Journal of Prosthodontic Research · doi:10.1016/j.jpor.2018.04.003 · Cited by 18
Metadata
- Authors
- Imamura, T., Doi, Y., Arima, H., Yonemoto, K., Hata, J., Kubo, M., Tanizaki, Y., Ibayashi, S., Iida, M., & Kiyohara, Y.
- Affiliations
- Kyushu University (JP)
- Venue
- Stroke
- Published
- 2009-02
- Volume
- 40
- Issue
- 2
- Pages
- 382-388
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2053503164
- Cited by
- 235
- References
- 37
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 13 · 2023: 16 · 2022: 14 · 2021: 9 · 2020: 16 · 2019: 22 · 2018: 20 · 2017: 10 · 2016: 12 · 2015: 7 · 2014: 9 · 2013: 18 · 2012: 9
- FWCI
- 13.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- Funders
- H2020 European Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- LDL cholesterol, stroke subtypes, coronary artery disease, atherothrombotic infarction, lacunar infarction, cardioembolic stroke, metabolic syndrome, stroke risk factors, Japanese population
- MeSH terms
- Age Factors, Aged, Analysis of Variance, Cardiovascular Diseases, Coronary Disease, Female, Follow-Up Studies, Health Surveys, Humans, Japan, Cholesterol, LDL, Male, Middle Aged, Myocardial Infarction, Terminology as Topic, Prospective Studies, Risk Factors, Sex Factors, Cohort Studies, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review